Home › Research › Biomarkers
Alzheimer’s disease blood-based biomarkers in the Boston Latino Aging Study (BLAST): Associations with cognition and depressive symptoms
Tristão-Pereira C, Silva G, Lopez KA, Ku V, Gonzalez A, Martinez JE, Giudicessi A, Rowe M et al.. medRxiv, 2026-10-15
Topic: Plasma and spinal-fluid biomarkers
Plain-language summary
Background Blood-based biomarkers (BBMs) may facilitate early detection of Alzheimer’s disease (AD), yet data in Latino populations remain limited. We examined associations of plasma biomarkers with cognition and depressive symptoms in Spanish-speaking Latino older adults enrolled in the Boston Latino Aging Study (BLAST). Methods Baseline data from 122 adults aged ≥55 years without dementia were analyzed. Plasma Aβ42/40, brain-derived phosphorylated tau (p-tau) 217, neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP) were measured using NULISA. Cognition was assessed with the Latin American Spanish version of the Preclinical Alzheimer’s Cognitive Composite (LAS-PACC5) and depressive symptoms with the Geriatric Depression Scale (GDS). Regression models were adjusted for age, sex, and education. Results Cognitively impaired participants had higher p-tau217 and GFAP than cognitively normal participants. Higher p-tau217 and GFAP were associated with poorer LAS-PACC5 performance, while higher NfL was associated with greater depressive symptoms. Aβ42/40 showed no significant associations. Conclusions Distinct biomarker associations with cognitive and emotional functioning support further longitudinal evaluation of BBMs for risk characterization in Latino older adults and potential disease monitoring applications.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Tristão-Pereira, C., Silva, G., Lopez, K. A., Ku, V., Gonzalez, A., Martinez, J. E., et al. (2026). Alzheimer’s disease blood-based biomarkers in the Boston Latino Aging Study (BLAST): Associations with cognition and depressive symptoms. medRxiv. https://doi.org/10.64898/2026.10.13.26365304
Vancouver
Tristão-Pereira C, Silva G, Lopez KA, Ku V, Gonzalez A, Martinez JE, et al. Alzheimer’s disease blood-based biomarkers in the Boston Latino Aging Study (BLAST): Associations with cognition and depressive symptoms. medRxiv. 2026. doi:10.64898/2026.10.13.26365304.
BibTeX
@article{tristaopereira2026-b88d713c,
author = {Tristão-Pereira, C. and Silva, G. and Lopez, K. A. and Ku, V. and Gonzalez, A. and Martinez, J. E. and Giudicessi, A. and Rowe, M. and others},
title = {{Alzheimer’s disease blood-based biomarkers in the Boston Latino Aging Study (BLAST): Associations with cognition and depressive symptoms}},
journal = {medRxiv},
year = {2026},
doi = {10.64898/2026.10.13.26365304},
url = {https://doi.org/10.64898/2026.10.13.26365304}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Results Cognitively impaired participants had higher p-tau217 and GFAP than cognitively normal participants.
- Higher p-tau217 and GFAP were associated with poorer LAS-PACC5 performance, while higher NfL was associated with greater depressive symptoms.
- Aβ42/40 showed no significant associations.
New to this subject? Start with our plain-English guide: Blood tests & biomarkers →
Study details
- Study designlongitudinal study
- Participants122
- Evidence strengthModerate
How this study scored 16/100
Preprint — not yet peer-reviewed. It scored 44 on the same rubric, but non-peer-reviewed sources are capped at 16, so it shows as 16. Scored zero for effect reported and randomized / blinded because the record does not state it. We have no data on times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record and multicenter collaboration, so those were left out: it earned 27 of the 62 points we could judge it on, which is 44 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 2 / 10 | Tier 4 — not a peer-reviewed journal (medRxiv) |
| Journal's citation record | 0 / 4 | Not a journal article, so the journal's record does not count |
| Study design | 7 / 12 | A longitudinal study following the same people over time |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 4 / 10 | Preprint — not yet peer-reviewed. Hosted on a preprint server. |
| How recent | 5 / 5 | 2026 — within 1 year(s) of the newest study here |
| Sample size | 2 / 4 | 122 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | — / 7 | No citation count (not found in OpenAlex) — left out of this score |
| Citations per year | — / 5 | No citation count or no year — left out of this score |
| Impact for its field and year | — / 6 | No field-weighted citation impact (OpenAlex has none yet) — left out of this score |
| Cited by studies here | — / 6 | Not yet checked against this library's citation graph — left out of this score |
| Still being cited | — / 4 | No yearly citation counts — left out of this score |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multicenter collaboration | — / 3 | Institutions not listed — left out of this score |
| Indexed in PubMed | 1 / 2 | Not in PubMed, but has a DOI |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Points | 27 / 62 | Scored on 12 of 20 parts. We have no data for the rest, so they are left out: 27 of the 62 points we could judge it on is 44 out of 100. |
| Total | 44 / 100 | Capped to 16 because this is not a peer-reviewed article. |
What each of these 20 components measures, and what this score is not →
Read the original
Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Biomarkers from nearby years
Also tagged “p-tau217”
692 studies in the library carry the topic tag “p-tau217”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 692 tagged studies.